Steve Jensen Joins The Weinberg Group (now ProPharma Group)

February 3, 2015

The Weinberg Group (now ProPharma Group), the leading FDA consulting firm, is pleased to announce that Steve Jensen has joined us as Senior Vice President, Head of Regulatory Consulting. Steve has over 20 years of industry experience including executive roles at Iroko, Verus and SkyePharma. He has had responsibility for products under development and launch, including managing multiple FDA submissions and meetings.
"Steve is a welcome addition to our team," said Matthew Weinberg, CEO. "His ability to synthesize a deep regulatory background in tandem with scientific expertise is the essence of what we do. His addition will strengthen the best team in the industry. We look forward to the leadership and guidance Steve will provide."
Steve Jensen

Senior Vice President, Head of Regulatory Consulting

+1 706.286.8841 direct

+1 706.371.8206 mobile

TAGS:

Related Articles

April 17, 2018

The Weinberg Group CEO to Speak at AIPPI’s International Convention on the Economy of Innovation

WASHINGTON, DC – April 17, 2018 – Matthew Weinberg, Chief Executive Officer of The Weinberg Group Inc., will be speaking at the International Association for the Protection of Intellectual Property’s...

Continue reading the blog post

October 3, 2018

The Weinberg Group (now ProPharma Group) Adds Experts to Team

WASHINGTON, DC – OCTOBER 3, 2018 – The Weinberg Group (now ProPharma Group), is growing. In addition to people, the company has also expanded its capabilities. Building upon its role as the most...

Continue reading the blog post

December 1, 2017

The Weinberg Group Donates to 21 Charities in Celebration of Giving Tuesday

WASHINGTON, DC – November 30, 2017 – The Weinberg Group Inc., a Washington, DC, based FDA consulting firm, today released a list of 21 charitable organizations that the firm contributed to on...

Continue reading the blog post